Erythropoietin: high profile, high scrutiny.
Publication
, Journal Article
Crawford, J
Published in: J Clin Oncol
March 20, 2007
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 20, 2007
Volume
25
Issue
9
Start / End Page
1021 / 1023
Location
United States
Related Subject Headings
- Treatment Outcome
- Risk Assessment
- Research Design
- Recombinant Proteins
- Randomized Controlled Trials as Topic
- Quality of Life
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Hematinics
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, J. (2007). Erythropoietin: high profile, high scrutiny. J Clin Oncol, 25(9), 1021–1023. https://doi.org/10.1200/JCO.2006.08.8153
Crawford, Jeffrey. “Erythropoietin: high profile, high scrutiny.” J Clin Oncol 25, no. 9 (March 20, 2007): 1021–23. https://doi.org/10.1200/JCO.2006.08.8153.
Crawford J. Erythropoietin: high profile, high scrutiny. J Clin Oncol. 2007 Mar 20;25(9):1021–3.
Crawford, Jeffrey. “Erythropoietin: high profile, high scrutiny.” J Clin Oncol, vol. 25, no. 9, Mar. 2007, pp. 1021–23. Pubmed, doi:10.1200/JCO.2006.08.8153.
Crawford J. Erythropoietin: high profile, high scrutiny. J Clin Oncol. 2007 Mar 20;25(9):1021–1023.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 20, 2007
Volume
25
Issue
9
Start / End Page
1021 / 1023
Location
United States
Related Subject Headings
- Treatment Outcome
- Risk Assessment
- Research Design
- Recombinant Proteins
- Randomized Controlled Trials as Topic
- Quality of Life
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Hematinics